Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors-Reference-Cited by-同舟云学术

Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors

Published:2017-02-08 Issue:4 Volume:60 Page:1598-1604
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Astolfi Andrea¹,Felicetti Tommaso¹,Iraci Nunzio¹,Manfroni Giuseppe¹,Massari Serena¹,Pietrella Donatella¹,Tabarrini Oriana¹,Kaatz Glenn W.²,Barreca Maria L.¹^ORCID,Sabatini Stefano¹^ORCID,Cecchetti Violetta¹

Affiliation:

1. Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy

2. John D. Dingell Department of Veterans Affairs Medical Center and the Department of Internal Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit, Michigan 48201, United States

Funder

U.S. Department of Veterans Affairs

Fondo per il sostegno della Ricerca di Base, Universit? degli Studi di Perugia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01439

Reference46 articles.

1. R-factor Mediated Dihydrofolate Reductases which Confer Trimethoprim Resistance

2. More extended-spectrum beta-lactamases